The present study deals with the chemical composition and antinociceptive effects of Plinia edulis fruit peels, analyzed by writhing, formalin, glutamate and capsaicin tests and comparison with two reference analgesic drugs, acetylsalicylic acid and acetaminophen. Phytochemical analyses of the nonpolar fraction (dichloromethane) obtained from the peels of P. edulis fruits revealed the presence of two triterpenes, maslinic acid and ursolic acid. The methanol extract of P. edulis peels showed a pronounced antinociceptive activity in the writhing test, with inhibition of 91.3% at 10 mg/kg, and its dichloromethane and ethyl acetate fractions presented inhibition of 68.3% and 51.5%, respectively. Maslinic acid showed a dose-dependent effect with inhibition of 60.8% at a dose of 10 mg/kg and ID 50 value of 3.31 (2.75 to 4.0) mg/kg. The dichloromethane fraction, evaluated in the formalin-induced pain model at a dose of 10 mg/kg, showed a significant effect on both phases of pain. Maslinic acid was evaluated at different doses (1, 3 and 6 mg/kg) and presented a dose-dependent profile in both phases of pain, being more effective than the reference drug (acetaminophen), which was evaluated at 10 mg/kg. The dichloromethane fraction also inhibited the pain induced by glutamate and capsaicin by around 54% and 44%, respectively, whereas maslinic acid was more effective against glutamate, with 62.5% inhibition at 6 mg/kg, and 32% inhibition against capsaicin-induced pain. The results demonstrated that the pronounced antinociceptive effect presented by P. edulis fruits peels is related, at least in part, to the presence of the triterpenes evidenced in this study.
Global recognition of the importance of nutrition and the increasing consumption of plant foods to prevent chronic diseases has prompted interest in their bioactive compounds. These phytochemicals present different chemical identities with several biological activities and mechanisms of action [1, 2] . The search for safer therapies with fewer side effects than synthetic drugs has led to increased attention to natural products. Herbal medicines have been widely used for centuries as an effective strategy for preventing and treating multiple health conditions [3, 4] .
Plinia edulis (Vell.) Sobral (Myrtaceae) is popularly known as "cambuca" or "cambucazeiro". It is an endemic fruit tree of Brazil, native to the coastal area of the Atlantic forest [5] [6] [7] . Several species of Myrtaceae, including P. edulis, have exhibited pharmacological properties and are used as hypoglycemic and therapeutic agents against stomach problems and throat infections [5, 8] . A recent study demonstrated that P. edulis leaf infusion presents antinociceptive and anti-inflammatory activities, which could be related to the presence of triterpenoids and flavonoids [9] .
We report here the chemical composition and antinociceptive effects of the methanol extract and its fractions of P. edulis fruit peels, analyzed by some classical models of pain in mice. We also tested an isolated triterpene and compare it with two reference analgesic drugs, acetyl salicylic acid and acetaminophen.
Phytochemical analyses of the nonpolar fraction (dichloromethane) obtained from the peels of P. edulis revealed the presence of two triterpenes, maslinic acid and ursolic acid. Both have been identified in the hexane fraction of the ethanol extract of the leaves of P. edulis [10] , and in P. edulis leaf infusion [9] . However, this is the first report of its presence in the fruit peels. Ishikawa and co-workers [10] also showed the presence in the hexane fraction of β-amyrin, lupeol and corosolic acid, and in the ethyl acetate fraction of gallic acid, quercitrin, myricetin and quercetin.
The methanol extract of P. edulis peels showed pronounced antinociceptive activity in the writhing test, with inhibition of 91.3% at 10 mg/kg (Table 1) , prompting continuation of the studies, since two well-known analgesic drugs, acetylsalicylic acid and acetaminophen, inhibited abdominal constrictions by about 35% at the same dose in this model. This extract was then fractionated by successive partitioning with dichloromethane and ethyl acetate, and its fractions were evaluated in the same model, with inhibition of 68.3% and 51.5%, respectively (Table 1) .
In a recent study with P. edulis leaf infusion, doses of 30-300 mg/kg produced anti-inflammatory effects and antinociceptive activity in the acetic acid-induced writhing response and mechanical nociceptive paw tests [9] . From the dichloromethane fraction, the most active constituents were isolated, one of which, maslinic acid (1), was selected for detailed study using the same model, administered i.p. at doses of 1, Figure 1 ). Considering its molar mass (472.7 g/mol), the inhibition can be expressed as an ID 50 value of 7.00 (5.82 to 8.46) µmol/kg, being about 19 times more potent than the reference drugs acetylsalicylic acid and acetaminophen, which exhibited ID 50 values of 133 and 125 µmol/kg, respectively [11] . Only one previous study has reported the antinocicpetive effects of this compound, but in other models and routes [12] , whereas ursolic acid (2) is well-known for its analgesic and antinociceptive potential [13] [14] [15] and was not included in our study. The dichloromethane fraction, evaluated in the formalin-induced pain model at a dose of 10 mg/kg, showed a significant effect on both phases of pain, being more effective than the reference drug (acetaminophen), as shown in Table 2 .
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Maslinic acid (1) was evaluated at different doses (1, 3 and 6 mg/kg) and presented a dose-dependent profile in both phases of pain, being more effective than the reference drug (acetaminophen), which was evaluated at 10 mg/kg. In addition, a reduction in edema of about 20% was also observed for the dichloromethane fraction (10 mg/kg), and of about 30% for 1 at 6 mg/kg, when compared with the control group ( Table 2) . Table 3 shows the effect of the dichloromethane fraction and 1 against glutamate and capsaicin-induced nociception in mice. The dichloromethane fraction was active against both models, inhibiting glutamate and capsaicin-induced pain by about 54% and 44%, respectively. Meanwhile, 1 was more effective against glutamate, with 62.5% inhibition at 6 mg/kg, with an ID 50 of 4.14 (3.87 -4.42) mg/kg or 8.76 (8.19 to 9.35) µmol/kg, with similar activity to the reference drug metamizole, which presented an ID 50 value of 9.0 (6.8 to 11.9) µmol/kg, while acetylsalicylic acid and acetaminophen were inactive in this model. Compound 1 also caused 32% inhibition against the pain induced by capsaicin at the same dose (Table 3) . These results suggest that the substances present in the dichloromethane fraction, particularly maslinic acid (1), may be acting in the inhibition of NO production or interacting with the glutamatergic system [16, 17] .
In conclusion, the results showed that the pronounced antinociceptive effect presented by the dichloromethane fraction of P. edulis peels is related, at least in part, to the presence of triterpenes 1 and 2 evidenced in this study. Current studies are in progress to confirm the biological properties in other models of pain in mice, as well as the mechanisms of action.
Experimental
Plant material: The fruits of P. edulis were collected in the town of Camboriú, Santa Catarina (Brazil), in March 2013. The plant material was authenticated by Professor Oscar B. Iza (UNIVALI), and the respective exsiccate was deposited at the Barbosa Rodrigues Herbarium (Itajaí-SC), under number VC Filho 121.
Preparation of extract and phytochemical analyses:
Fresh peels of the fruit of P. edulis (350 g) were macerated with methanol for 7 days. The solvent was then evaporated in a rotatory evaporator, under reduced pressure, at approximately 50°C, yielding the respective crude methanol extract (12 g; 3.43%). Part of this (2 g) was subjected to liquid-liquid partition using dichloromethane and ethyl acetate, furnishing the respective fractions with yields of 5% and 3.75% respectively.
Isolation of maslinic acid (1) and ursolic acid (2):
The dichloromethane fraction (100 mg) was directly chromatographed on a silica gel column eluted with n-hexane: ethyl acetate (100:0  0:100) in increasing order of polarity, to afford 50 fractions (10 mL each), which were combined based on TLC profiles, using nhexane: ethyl acetate (80:20) as the mobile phase and reaction with sulfuric anisaldehyde heated to 100 o C. Fractions 9-16 (compound 1, 13 mg) and 17-21 (compound 2, 16 mg) were identified using spectral data (NMR) in comparison with the literature [18] , co-TLC with authentic samples, and confirmed by direct-injection mass spectrometry (DIMS) as maslinic acid (1) and ursolic acid (2).
Animals:
Male Swiss mice (25-35 g), housed at 22 ± 2°C under a 12 h light/12 h dark cycle and with access to food and water ad libitum, were acclimatized to the laboratory for at least 1 h prior to testing. The experiments reported here were carried out in accordance with the current ethical guidelines for the care of laboratory animals and the investigation of experimental pain in conscious animals [19] . The experiments were approved by the local Ethics Committee of this Institution (005/14 UNIVALI). The number of animals (6-8 for group of treatment) and intensities of noxious stimuli used were the minimum necessary to demonstrate consistent effects of the drug treatments. Acetic acid-induced writhing: Abdominal constriction was induced by intraperitoneal injection of acetic acid (0.6%), according to the previously described procedure, with minor modifications [20] . Animals were pre-treated with the methanol extract (10 mg/kg), dichloromethane and ethyl acetate fractions (10 mg/kg) and maslinic acid (1) (1, 3 and 6 mg/kg), intraperitoneally (i.p.), 30 min before the acetic acid injection, respectively (6 animals in each group). The control animals received a similar volume of 0.9% NaCl (10 mL/kg, i.p.). After the challenge, pairs of mice were placed in separate glass funnels, and the number of contractions of the abdominal muscles, together with stretching, were counted cumulatively over a period of 20 min. Antinociceptive activity was expressed as the reduction in the number of abdominal contractions between the control animals and the mice pretreated with the test materials [11, 20] .
Formalin-induced nociception:
The procedure used was similar to that described by Hunskaar, Fasmar and Hole [21] , with minor modifications. The observation chamber was a cylinder of 20 cm in diameter, equipped with a mirror at a 45° angle to allow clear observation of the animals' legs. The mice were treated with a solution of the dichloromethane fraction of P. edulis peels (10 mg/kg), maslinic acid (1) (1, 3 and 6 mg/kg), or saline (control animals), intraperitoneally, 30 min before receiving the formalin injection. Each animal was placed in the chamber 5 min before treatment to allow them to acclimatize to the new environment. Twenty mL of 2.5% formalin solution in 0.9% saline was injected intraplantarly into the animal's right hind paw. The animal was then returned to the chamber, and the time spent licking the paw that received the injection was considered as indicative of pain. Two separate phases were identified: an acute phase 0-5 min after formalin injection, and a chronic phase, 15-30 min after formalin injection. At the end of the experiments, the animals were sacrificed and the paws cut at the tibiotarsal joint and weighed on an analytical balance to investigate the interference of the extract and compound 1 on formalin-induced inflammatory edema.
Glutamate-induced nociception: Similar to the procedure described by Beirith, Santos and Calixto [16] , animals were treated with the dichloromethane fraction of P. edulis peels (10 mg/kg), maslinic acid (1) (6 mg/kg i.p.) or vehicle (10 mL/kg, 0.9 % NaCl solution)
30 min before glutamate injection. Twenty L glutamate solution (30 mol/ paw), made up in saline (NaCl solution), was injected intraplantarly under the surface of the right hind paw, as described previously. After injection with glutamate, the animals were individually placed in glass cylinders of 20 cm in diameter and observed for 0 to 15 min. The time spent licking and biting the injected paw was timed with a chronometer and was considered as indicative of pain.
Capsaicin-induced nociception:
The procedure used was similar to that described previously [22] . Animals were placed individually in transparent glass cylinders. Following the adaptation period, 20 L of capsaicin solution (1.6 g/paw) was injected under the skin of the plantar surface of the right hind paw, using a micro syringe. The animals were observed individually for 5 min following capsaicin injection. The amount of time spent licking the injected paw was timed with a chronometer, and was considered as indicative of nociception. The animals were treated intraperitoneally with the dichloromethane fraction of P. edulis peels (10 mg/kg) and maslinic acid (1) (1, 3 and 6 mg/kg), or vehicle (10 mL/kg, 0.9 % NaCl solution), 30 min before administration of capsaicin.
Statistical analysis:
The results are presented as means of 6 experimental values, except for the mean ID 50 values (i.e., the dose of extracts or fractions that reduce the analgesic responses by 50% compared with the control value), which are reported as geometric means accompanied by their respective 95% confidence limits. The statistical significance between groups was analyzed by one-way ANOVA followed by Dunnett's post-test, unless otherwise stated. P values of less than 0.05 were considered indicative of significance.
ID 50 values were determined by graphic interpolation from individual experiments.
